Physician

David R Drosick, MD

According to 2025 Medicare claims, David Drosick, MD (NPI: 1699768499) practices medical oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY CARE INC (NPI: 1790778041; TIN: 311106418) and primary practice location at 45245-1898. Drosick is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Drosick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 725 traditional Medicare patients, billed 120,631 HCPCS/CPT codes, and received $2,207,756 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 3,509 prescription claims across 470 beneficiaries totaling $6,021,917 in drug costs, led by Ibrance (Palbociclib). DME data shows 45 claims. Open Payments data shows 53 records totaling $1,666. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $963,286 to $6,021,917. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $9,584 to $408.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	800	134,936	$1,384,303
2016	960	182,670	$1,997,566
2017	1,006	135,869	$1,898,057
2018	887	139,896	$2,207,611
2019	865	193,072	$2,381,187
2020	815	163,094	$2,347,259
2021	832	184,303	$2,575,777
2022	751	148,280	$2,120,069
2023	712	116,339	$2,301,333
2024	725	120,631	$2,207,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	284	2,106	$963,286
2016	331	2,567	$1,596,636
2017	342	2,989	$2,696,421
2018	374	3,132	$3,275,026
2019	427	3,348	$4,618,486
2020	401	3,366	$4,811,268
2021	404	3,274	$5,408,873
2022	394	3,021	$5,097,567
2023	413	2,779	$5,387,617
2024	470	3,509	$6,021,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	189	$11,421
2016	46	233	$10,945
2017	N/R	105	$5,578
2018	11	136	$7,147
2019	N/R	66	$2,486
2020	N/R	194	$11,876
2021	N/R	155	$9,198
2022	N/R	177	$11,023
2023	N/R	81	$11,681
2024	N/R	45	$1,210

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	489	920	$59
82728	Ferritin (blood protein) level	107	158	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	355	587	$11
80053	Blood test, comprehensive group of blood chemicals	429	956	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	443	1,091	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	124	3,472	$1,920,435
Calquence	Acalabrutinib Maleate	51	1,530	$601,894
Revlimid	Lenalidomide	28	784	$558,092
Imbruvica	Ibrutinib	44	1,258	$541,452
Verzenio	Abemaciclib	30	840	$420,459

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$411
E1392	Portable oxygen concentrator, rental	Y	N/R	11	$369
A4394	Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce	N	N/R	11	$222
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,666	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David R. Drosick, MD?

Tedicare shows public-source Medicare data for David R. Drosick, MD (NPI 1699768499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David R. Drosick, MD have ACO affiliation data?

David R. Drosick, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to David R. Drosick, MD?

David R. Drosick, MD is linked to ONCOLOGY HEMATOLOGY CARE INC (billing NPI 1790778041) in the available physician profile data.

Does David R. Drosick, MD have Open Payments data?

David R. Drosick, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.